A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs

被引:18
|
作者
Spelman, T. [1 ]
Morris, M. D. [2 ]
Zang, G. [3 ]
Rice, T. [2 ]
Page, K. [4 ]
Maher, L. [5 ]
Lloyd, A. [6 ]
Grebely, J. [5 ]
Dore, G. J. [5 ]
Kim, A. Y. [7 ,8 ]
Shoukry, N. H. [3 ]
Hellard, M. [1 ]
Bruneau, J. [3 ]
机构
[1] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Montreal, CRCHUM, Montreal, PQ H2X 0A9, Canada
[4] Univ New Mexico, Hlth Sci Ctr, Dept Epidemiol Biostat & Prevent Med, Albuquerque, NM 87131 USA
[5] UNSW Australia, Kirby Inst, Sydney, NSW, Australia
[6] UNSW Australia, Sydney, NSW, Australia
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Harvard Univ, Sch Med, Boston, MA USA
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
OPIATE SUBSTITUTION THERAPY; ALCOHOL-CONSUMPTION; RISK BEHAVIOR; LIVER-DISEASE; GLOBAL BURDEN; USERS; EQUIPMENT; IMPACT; HIV; SEROCONVERSION;
D O I
10.1136/jech-2014-205224
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Hepatitis C virus (HCV) testing and counselling have the potential to impact individual behaviour and transmission dynamics at the population level. Evidence of the impact of an HCV-positive status notification on injection risk reduction is limited. The objective of our study was to (1) assess drug and alcohol use and injection risk behaviours following notification; (2) to compare behaviour change in people who inject drugs (PWID) who received a positive test result and those who remained negative; and (3) to assess the effect of age on risk behaviour. Methods Data from the International Collaboration of Incident HIV and HCV Infection in Injecting Cohorts (InC3 Study) were analysed. Participants who were initially HCV seronegative were followed prospectively with periodic HCV blood testing and post-test disclosure and interview-administered questionnaires assessing drug use and injection behaviours. Multivariable generalised estimating equations were used to assess behavioural changes over time. Results Notification of an HCV-positive test was independently associated with a small increase in alcohol use relative to notification of a negative test. No significant differences in postnotification injection drug use, receptive sharing of ancillary injecting equipment and syringe borrowing postnotification were observed between diagnosis groups. Younger PWID receiving a positive HCV test notification demonstrated a significant increase in subsequent alcohol use compared with younger HCV negative. Conclusions The proportion of PWID reporting alcohol use increased among those receiving an HCV-positive notification, increased the frequency of alcohol use postnotification, while no reduction in injection drug use behaviours was observed between notification groups. These findings underscore the need to develop novel communication strategies during post-test notification to improve their impact on subsequent alcohol use and risk behaviours.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [41] Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada
    Jacka, Brendan
    Applegate, Tanya
    Poon, Art F.
    Raghwani, Jayna
    Harrigan, P. Richard
    DeBeck, Kora
    Milloy, M. -J.
    Krajden, Mel
    Olmstead, Andrea
    Joy, Jeffrey B.
    Marshall, Brandon D. L.
    Hayashi, Kanna
    Pybus, Oliver G.
    Lima, Viviane Dias
    Magiorkinis, Gkikas
    Montaner, Julio
    Lamoury, Francois
    Dore, Gregory J.
    Wood, Evan
    Grebely, Jason
    JOURNAL OF HEPATOLOGY, 2016, 64 (06) : 1247 - 1255
  • [42] Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs
    Treloar, Carla
    Hull, Peter
    Dore, Gregory J.
    Grebely, Jason
    DRUG AND ALCOHOL REVIEW, 2012, 31 (07) : 918 - 924
  • [43] Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India
    Solomon S.S.
    Boon D.
    Saravanan S.
    Srikrishnan A.K.
    Vasudevan C.K.
    Balakrishnan P.
    Persaud D.
    Ray S.C.
    Mehta S.
    Mehta S.H.
    VirusDisease, 2019, 30 (4) : 490 - 497
  • [44] Infection of human pegivirus 2 (HPgV-2) is associated with hepatitis C virus but not hepatitis B virus infection in people who inject drugs
    Shui, Jingwei
    Liu, Wenpei
    Liang, Yuanhao
    Zhang, Jian
    Wan, Zhengwei
    Wang, Haiying
    Qu, Xiaowang
    Tang, Shixing
    JOURNAL OF GENERAL VIROLOGY, 2019, 100 (06): : 968 - 974
  • [45] Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018
    Stvilia, Ketevan
    Spradling, Philip R.
    Asatiani, Alexander
    Gogia, Maka
    Kutateladm, Khatuna
    Butsashvili, Maia
    Zarkua, Jaba
    Tsertsvadze, Tengiz
    Sharvadze, Lali
    Japaridze, Maia
    Kuchuloria, Tinatin
    Gvinjilia, Lia
    Tskhomelidze, Irinka
    Gamkrelidze, Amiran
    Khonelidze, Irma
    Sergeenko, David
    Shadaker, Shaun
    Averhoff, Francisco
    Nasrullah, Muazzam
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (29): : 637 - 641
  • [46] Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium
    Mathei, Catharina
    Bourgeois, Stefan
    Blach, Sarah
    Brixko, Christian
    Mulkay, Jean-Pierre
    Razavi, Homie
    Robaeys, Geert
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2016, 79 (02): : 227 - 232
  • [47] Hepatitis C Virus Dynamic Transmission Models Among People Who Inject Drugs
    Woyesa, Shiferaw Bekele
    Amente, Kellemuwa Desalegn
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 1061 - 1068
  • [48] Hepatitis C Virus Serosorting in People Who Inject Drugs: Sorting Out the Details
    Kim, Arthur Y.
    Page, Kimberly
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (12): : 1929 - 1931
  • [49] Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review
    Bajis, Sahar
    Dore, Gregory J.
    Hajarizadeh, Behzad
    Cunningham, Evan B.
    Maher, Lisa
    Grebely, Jason
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 34 - 46
  • [50] People with Hepatitis C Who Inject Drugs - Underserved, Not Undeserving
    Dore, Gregory J.
    Trooskin, Stacey
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07): : 608 - 611